APA (7th ed.) Citation

M, B., K, A., M, B., M, B., E, B., BC, F., . . . JD, L. (2022). Inhaled aviptadil for the possible treatment of COVID-19 in patients at high risk for ARDS: Study protocol for a randomized, placebo-controlled, and multicenter trial. Trials, 23(1), 790. https://doi.org/10.1186/s13063-022-06723-w

Chicago Style (17th ed.) Citation

M, Boesing, et al. "Inhaled Aviptadil for the Possible Treatment of COVID-19 in Patients at High Risk for ARDS: Study Protocol for a Randomized, Placebo-controlled, and Multicenter Trial." Trials 23, no. 1 (2022): 790. https://doi.org/10.1186/s13063-022-06723-w.

MLA (9th ed.) Citation

M, Boesing, et al. "Inhaled Aviptadil for the Possible Treatment of COVID-19 in Patients at High Risk for ARDS: Study Protocol for a Randomized, Placebo-controlled, and Multicenter Trial." Trials, vol. 23, no. 1, 2022, p. 790, https://doi.org/10.1186/s13063-022-06723-w.